General anaesthesia
ProcedureIntravenous or volatile general anesthesia was preformed with different type of airway management (endotracheal tube, laryngeal mask and bag mask ventilation)
NCT Number: NCT06526130
The influence of anesthesia on the course of multiple sclerosis is poorly investigated and the literature is limited.
The aim of this study is to investigate multiple sclerosis relapse after different types of anesthesia.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
The influence of anesthesia on the course of multiple sclerosis is poorly investigated and the literature is limited. A possible relapse after neuraxial anesthesia, it is believed to be associated with local anesthetic's toxicity and concentration.
The aim of this study is to investigate multiple sclerosis relapse after different types of anesthesia.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intravenous or volatile general anesthesia was preformed with different type of airway management (endotracheal tube, laryngeal mask and bag mask ventilation)
spinal or epidural injections of local anesthetic with or without opioid
Time frame: 1 month
Overall incidence of multiple sclerosis relapse after 1 month after anaesthesia
Time frame: 3 months
Overall incidence of multiple sclerosis relapse after 3 months after anaesthesia
Time frame: 6 months
Overall incidence of multiple sclerosis relapse after 6 months after anaesthesia
Time frame: 12 months
Overall incidence of multiple sclerosis relapse after 12 months after anaesthesia
Varazdin General Hospital
Other
Multiple Sclerosis Comparison of Relapse Incidence After General and Neuraxial Anesthesia: a Retrospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05116540
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Sugar Land, Texas, United States
View Trial DetailsNCT05449574
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Szczecin, Unii Lubelskiej, Poland
View Trial DetailsNCT00509145
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Phoenix, Arizona, United States
View Trial DetailsNCT02440126
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Salt Lake City, Utah, United States
View Trial Details